Marshall Wace, LLP Argenx Se Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Argenx Se stock. As of the latest transaction made, Marshall Wace, LLP holds 67,282 shares of ARGX stock, worth $42.9 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

67,282

Previous 113,772 40.86%

Holding current value

$42.9 Million

Previous $48.9 Million 25.42%

% of portfolio

0.05%

Previous 0.07%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$434.22 - $551.9 $20.2 Million - $25.7 Million	-46,490 Reduced 40.86%	67,282 $36.5 Million
Q2 2024 Aug 14, 2024	SELL	$356.01 - $451.55 $1.02 Million - $1.29 Million	-2,863 Reduced 2.45%	113,772 $48.9 Million
Q1 2024 May 15, 2024	SELL	$356.95 - $413.29 $3.23 Million - $3.73 Million	-9,036 Reduced 7.19%	116,635 $45.9 Million
Q4 2023 Feb 14, 2024	SELL	$338.91 - $506.01 $62 Million - $92.5 Million	-182,877 Reduced 59.27%	125,671 $47.8 Million
Q3 2023 Nov 14, 2023	BUY	$369.35 - $548.43 $43 Million - $63.9 Million	116,433 Added 60.61%	308,548 $152 Million
Q2 2023 Aug 14, 2023	BUY	$360.14 - $422.58 $1.51 Million - $1.77 Million	4,181 Added 2.22%	192,115 $74.9 Million
Q1 2023 May 15, 2023	BUY	$334.23 - $403.65 $19.1 Million - $23.1 Million	57,274 Added 43.83%	187,934 $70 Million
Q4 2022 Feb 14, 2023	BUY	$342.17 - $402.31 $10.1 Million - $11.8 Million	29,428 Added 29.07%	130,660 $49.5 Million
Q3 2022 Nov 14, 2022	BUY	$343.2 - $395.75 $34.7 Million - $40.1 Million	101,232 New	101,232 $35.7 Million
Q1 2022 May 16, 2022	SELL	$254.45 - $351.06 $391,853 - $540,632	-1,540 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$272.01 - $353.03 $2.64 Million - $3.43 Million	-9,705 Reduced 86.31%	1,540 $540,000
Q3 2021 Nov 15, 2021	BUY	$295.0 - $350.58 $3.32 Million - $3.94 Million	11,245 New	11,245 $3.4 Million
Q4 2019 Feb 14, 2020	SELL	$106.59 - $164.21 $37,626 - $57,966	-353 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$113.31 - $150.51 $39,998 - $53,130	353 New	353 $40,000
Q2 2019 Aug 14, 2019	SELL	$115.0 - $141.58 $111,895 - $137,757	-973 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$98.85 - $134.59 $96,181 - $130,956	973 New	973 $121,000
Q4 2018 Feb 14, 2019	SELL	$63.81 - $109.82 $477,107 - $821,124	-7,477 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$75.5 - $96.63 $564,513 - $722,502	7,477 New	7,477 $567,000

Others Institutions Holding ARGX

# of Institutions

401

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $35.3B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Argenx Se Transaction History